Birchview Capital as of Sept. 30, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 50 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 32.0 | $48M | 794k | 60.29 | |
| Accelr8 Technology | 15.6 | $23M | 2.2M | 10.66 | |
| Quidel Corporation | 8.6 | $13M | 59k | 219.37 | |
| Aspira Womens Health | 6.4 | $9.5M | 3.1M | 3.08 | |
| Neurocrine Biosciences (NBIX) | 5.0 | $7.5M | 78k | 96.15 | |
| ACADIA Pharmaceuticals (ACAD) | 2.8 | $4.2M | 102k | 41.25 | |
| Bluebird Bio (BLUE) | 2.2 | $3.2M | 60k | 53.95 | |
| Biogen Idec (BIIB) | 2.1 | $3.1M | 11k | 283.64 | |
| Bmy Cvr Rts 03/31/21 Right | 1.8 | $2.7M | 707k | 3.84 | |
| Karyopharm Therapeutics (KPTI) | 1.6 | $2.5M | 168k | 14.60 | |
| Acceleron Pharma | 1.4 | $2.1M | 19k | 112.52 | |
| Soleno Therapeutics | 1.4 | $2.1M | 827k | 2.51 | |
| Oxford Immunotec Global | 1.3 | $2.0M | 170k | 11.70 | |
| Albireo Pharma | 1.3 | $1.9M | 58k | 33.36 | |
| Masimo Corporation (MASI) | 1.3 | $1.9M | 8.0k | 236.00 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $1.8M | 18k | 101.00 | |
| Arena Pharmaceuticals | 1.1 | $1.6M | 22k | 74.77 | |
| Chemocentryx | 1.1 | $1.6M | 30k | 54.80 | |
| Myokardia | 0.9 | $1.4M | 10k | 136.30 | |
| Contrafect | 0.9 | $1.3M | 256k | 5.28 | |
| Amarin Corp Spons Adr New (AMRN) | 0.8 | $1.3M | 300k | 4.21 | |
| Equitrans Midstream Corp (ETRN) | 0.8 | $1.1M | 133k | 8.46 | |
| Harrow Health (HROW) | 0.7 | $1.0M | 180k | 5.59 | |
| Corcept Therapeutics Incorporated (CORT) | 0.6 | $870k | 50k | 17.40 | |
| Epizyme | 0.6 | $835k | 70k | 11.93 | |
| Vanda Pharmaceuticals (VNDA) | 0.5 | $773k | 80k | 9.66 | |
| ImmunoGen | 0.5 | $684k | 190k | 3.60 | |
| Stoke Therapeutics (STOK) | 0.4 | $670k | 20k | 33.50 | |
| Biohaven Pharmaceutical Holding | 0.4 | $650k | 10k | 65.00 | |
| Amicus Therapeutics (FOLD) | 0.4 | $537k | 38k | 14.13 | |
| Inari Medical Ord (NARI) | 0.3 | $483k | 7.0k | 69.00 | |
| Xencor (XNCR) | 0.3 | $477k | 12k | 38.78 | |
| Continental Resources | 0.3 | $474k | 39k | 12.28 | |
| G1 Therapeutics (GTHX) | 0.3 | $462k | 40k | 11.55 | |
| Progyny (PGNY) | 0.3 | $441k | 15k | 29.40 | |
| Translate Bio | 0.3 | $408k | 30k | 13.60 | |
| Tg Therapeutics (TGTX) | 0.3 | $401k | 15k | 26.73 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $378k | 30k | 12.60 | |
| Arvinas Ord (ARVN) | 0.2 | $354k | 15k | 23.60 | |
| Intercept Pharmaceuticals In | 0.2 | $344k | 8.3k | 41.45 | |
| Pioneer Natural Resources (PXD) | 0.2 | $327k | 3.8k | 86.05 | |
| Voyager Therapeutics (VYGR) | 0.2 | $320k | 30k | 10.67 | |
| Inflarx Nv (IFRX) | 0.2 | $298k | 70k | 4.26 | |
| Encana Corporation (OVV) | 0.2 | $280k | 34k | 8.15 | |
| Odonate Therapeutics Ord | 0.2 | $269k | 20k | 13.45 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $241k | 8.0k | 30.12 | |
| Workhorse Group Inc ordinary shares (WKHS) | 0.1 | $202k | 8.0k | 25.25 | |
| Dicerna Pharmaceuticals | 0.1 | $180k | 10k | 18.00 | |
| Yield10 Bioscience | 0.1 | $147k | 19k | 7.76 | |
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $69k | 20k | 3.45 |
